Subjective but not objective numeracy influences willingness to pay for BRCA1/2 genetic testing
A positive test result for BRCA1/2 gene mutation is a substantial risk factor for breast and ovarian cancer. However, testing is not always covered by insurance, even for high risk women. Variables affecting willingness to pay (WTP) have implications for clinic-based and direct-to-consumer testing....
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2014-03-01
|
Series: | Judgment and Decision Making |
Subjects: | |
Online Access: | http://journal.sjdm.org/13/131116/jdm131116a.pdf |